Medtronic plcMDTNYSE

Overview Intelligence Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 54% recommend buying.

Consensus Rating

Buy

26 analysts·High coverage

54%

Rating Distribution

Strong Buy

00%

Buy

1454%

Hold

1246%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 14% higher.

Bear Case

$100.00

+2%

Consensus

$111.64

+14%

Bull Case

$121.00

+23%

Price Range26 analysts

Low

Consensus

High

$100.00

$121.00

Current Target

Current Price

$98.10

Upside to Target

$13.54

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$5.65(18 analysts)

P/E27x

Current: 27.1x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+6.85%

EPS+7.85%

FY2028

Rev+5.18%

EPS+7.35%

FY2029

Rev+6.49%

EPS+9.40%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+2.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 18, 2026Robert W. Baird

Medtronic price target lowered to $100 from $103 at Baird

Target:$100.00

+3.7%from $96.41

Feb 18, 2026Barclays

Medtronic price target raised to $118 from $116 at Barclays

Target:$118.00

+22.4%from $96.41

Feb 9, 2026Needham

Medtronic upgraded to Buy from Hold at Needham

Target:$121.00

+17.6%from $102.90

Feb 4, 2026UBS

Medtronic price target raised to $104 from $103 at UBS

Target:$104.00

+0.6%from $103.38

Jan 30, 2026Wells Fargo

Medtronic resumed with an Overweight at Wells Fargo

Target:$114.00

+12.0%from $101.78

Jan 9, 2026Bernstein

Medtronic price target raised to $112 from $111 at Bernstein

Target:$112.00

+13.5%from $98.69

Jan 8, 2026Barclays

Medtronic price target raised to $116 from $111 at Barclays

Target:$116.00

+16.3%from $99.77

Dec 18, 2025Truist Financial

Medtronic price target lowered to $107 from $110 at Truist

Target:$107.00

+7.9%from $99.14

Dec 16, 2025Robert W. Baird

Medtronic price target lowered to $103 from $109 at Baird

Target:$103.00

+4.4%from $98.67

Nov 20, 2025Barclays

Medtronic price target raised to $111 from $109 at Barclays

Target:$111.00

+10.6%from $100.34

Nov 19, 2025Bernstein

Medtronic price target raised to $111 from $98 at Bernstein

Target:$111.00

+10.6%from $100.34

Nov 19, 2025Leerink Partners

Medtronic, Inc. (MDT) PT Raised to $120 at Leerink Partners

Target:$120.00

+19.0%from $100.80

Nov 19, 2025Jefferies

Medtronic, Inc. (MDT) PT Raised to $110 at Jefferies

Target:$110.00

+9.1%from $100.80

Nov 19, 2025Goldman Sachs

Goldman Sachs Upgrades Medtronic, Inc. (MDT) to Neutral

Target:$111.00

+10.1%from $100.80

Oct 31, 2025Bernstein

Bernstein SocGen Group Reiterates Outperform Rating on Medtronic, Inc. (MDT), can RDN be the biggest thing MDT ever does?

Target:$98.00

+7.5%from $91.17

Oct 15, 2025Truist Financial

Medtronic price target raised to $103 from $96 at Truist

Target:$103.00

+8.1%from $95.26

Oct 10, 2025RBC Capital

Medtronic price target raised to $111 from $103 at RBC Capital

Target:$111.00

+16.0%from $95.72

Aug 26, 2025Argus Research

Medtronic price target raised to $115 from $105 at Argus

Target:$115.00

+24.8%from $92.18

Jan 8, 2025Bernstein

Medtronic price target lowered to $93 from $97 at Bernstein

Target:$93.00

+12.5%from $82.68

Oct 15, 2024Robert W. Baird

Medtronic, Inc. (MDT) PT Raised to $96 at Baird

Target:$96.00

+6.7%from $90.01

Oct 10, 2024RBC Capital

Medtronic upgraded to Outperform from Sector Perform at RBC Capital

Target:$105.00

+18.8%from $88.35

Oct 1, 2024Evercore ISI

Medtronic target raised, added to 'Tactical Outperform' list at Evercore ISI

Target:$104.00

+15.5%from $90.03

Oct 1, 2024Citigroup

Medtronic price target raised to $92 from $85 at Citi

Target:$92.00

+2.2%from $90.03

Aug 21, 2024Goldman Sachs

Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)

Target:$82.00

-5.1%from $86.40

Aug 21, 2024Oppenheimer

Medtronic, Inc. (MDT) PT Raised to $94 at Oppenheimer

Target:$94.00

+8.7%from $86.46

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance